IDEXX Laboratories, Inc. Announces Senior Leadership Changes in Support of Global Companion Animal Group Growth
January 15, 2020 at 06:00 pm IST
Share
IDEXX Laboratories, Inc. announced organizational changes to its global Companion Animal Group (CAG) business aligned with leveraging best practices and execution capabilities to support global market development and sustained double-digit revenue growth. The following leadership changes in the Company's global CAG commercial organization will enhance its global CAG commercial efforts and foster greater integration and efficiencies across regions: James Polewaczyk, who has led the Company's North America Commercial Operations since its go-direct initiative in 2014, has been promoted to Chief Commercial Officer and Executive Vice President and will now oversee CAG Commercial Operations globally. Kathy Turner, who has led the Company's Commercial Operations for CAG in Europe and Asia since May 2014, has been appointed Chief Marketing Officer. In this new role, Ms. Turner will be responsible for the Company's commercial marketing efforts worldwide, including global medical affairs and global marketing centers of excellence. Dr. Michael Erickson, who has led IDEXX'sVeterinary Software and Services line of business since joining the Company in 2011, assumed responsibility for IDEXX's North America Corporate Accounts in 2019 and will now lead Global Corporate Accounts to support these strategic partners on an increasingly global basis. In addition, IDEXX is making the following organizational changes in its CAG lines of business: Dr. Tina Hunt, who has a proven leadership track record of almost 15 years at IDEXX, has been promoted to Executive Vice President. Dr. Hunt will retain global responsibility for IDEXX's in-clinic companion animal diagnostics portfolio and will also take on responsibility for IDEXX's worldwide operations; Michael Lane, with over two decades of leadership contributions to IDEXX, has been promoted to Executive Vice President, with continued accountability for IDEXX'sGlobal Reference Laboratories, while additionally taking on responsibility for IDEXX's worldwide information technology organization. Under the enhanced organizational structure, which is effective immediately, the leadership team will continue to report to Jay Mazelsky, President and Chief Executive Officer.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows:
- veterinary diagnoses for pets (91.6%);
- water quality analysis (4.6%);
- veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products;
- other (0.5%).
Net sales by source of income break down between product sales (57.1%) and services (42.9%).
Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
IDEXX LABORATORIES, INC. 
